December 26, 2019

Future of Due Diligence in Healthcare M&A

December, 2019

Large corporate mergers and spin-offs, biotech and technology breakthroughs, and stronger-than-ever data privacy requirements make the healthcare sector one rich with opportunity and risk. That means staying on top of due diligence best practices has never been more important.

The good news is that innovative trends are accelerating due diligence across all industries.

Download our latest whitepaper now to explore:

  • Distinct challenges facing the healthcare industry
  • Key factors driving new due diligence trends
  • Extensive polling and survey results from industry peers and leaders
  • Technology advances to ease the due diligence challenge

You may also like:

Deal Drivers: APAC Q1 2022

M&A activity across the APAC region as a whole slipped in Q1, which was to be expected after a record-setting 2021. It’s a trend that can be observed across geographic markets an is best understood as a reversion to the mean rather than a cause for concern at this stage. Learn more from our latest Deal Drivers report.

Deal Drivers: EMEA Q1 2022

After a stellar 2021, M&A markets around the world experienced a return to levels more in line with historic precedent in Q1 2022. EMEA was no exception, with deal values and volumes declining. But bright spots persisted. Find out how EMEA M&A performed in Q1 2022 and what lies ahead for the region.

Deal Drivers: Americas Q1 2022 Report

After the ferocious momentum of 2021, dealmaking in the Americas has been easing down in recent months. Not so much a decline as a return to business as usual, the first quarter of 2022 offers clearer indications of what lies ahead.